Cite
Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma.
MLA
Suwanchiwasiri, Kwanpirom, et al. “Bispecific T Cell Engager-Armed T Cells Targeting Integrin Ανβ6 Exhibit Enhanced T Cell Redirection and Antitumor Activity in Cholangiocarcinoma.” Biomedicine & Pharmacotherapy, vol. 175, June 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.116718.
APA
Suwanchiwasiri, K., Phanthaphol, N., Somboonpatarakun, C., Yuti, P., Sujjitjoon, J., Luangwattananun, P., Maher, J., Yenchitsomanus, P., & Junking, M. (2024). Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma. Biomedicine & Pharmacotherapy, 175, N.PAG. https://doi.org/10.1016/j.biopha.2024.116718
Chicago
Suwanchiwasiri, Kwanpirom, Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Pornpimon Yuti, Jatuporn Sujjitjoon, Piriya Luangwattananun, John Maher, Pa‑thai Yenchitsomanus, and Mutita Junking. 2024. “Bispecific T Cell Engager-Armed T Cells Targeting Integrin Ανβ6 Exhibit Enhanced T Cell Redirection and Antitumor Activity in Cholangiocarcinoma.” Biomedicine & Pharmacotherapy 175 (June): N.PAG. doi:10.1016/j.biopha.2024.116718.